{
  "type": "hyp",
  "text": "In circulating T cells from a subset of patients with RCCs the suppression of NFkappaB binding activity is downstream from the stimulus-induced degradation of the cytoplasmic factor IkappaBalpha. However secretion of IL-2 by anti-CD3-stimulated T cells was still blunted compared with control cells from adults.\n",
  "self": {
    "NER": {
      "answers": [
        "NFkappaB",
        "IkappaBalpha",
        "IL-2"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What binding activity is downstream from the degradation of the cytoplasmic factor?",
          "What cytoplasmic factor is involved in the suppression of NFkappaB binding",
          "What protein was secreted by anti-CD3-stimulated T cells?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "T cells",
        "a subset",
        "patients",
        "RCCs",
        "the suppression",
        "NFkappaB binding activity",
        "the stimulus-induced degradation",
        "the cytoplasmic factor",
        "IkappaBalpha",
        "secretion",
        "anti-CD3-stimulated T cells",
        "control cells",
        "adults"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What type of cells were used to suppress NFkappaB binding?",
          "What group of patients had RCCs?",
          "What group of patients had a lower level of NFkappaB binding activity?",
          "What type of patients had a lower level of NFkappaB binding activity?",
          "What is downstream from the degradation of the cytoplasmic factor IkappaBal",
          "What is downstream from the degradation of the cytoplasmic factor IkappaBal",
          "What is downstream of NFkappaB binding activity?",
          "What does the stimulation of NFkappaB binding activity downstream from?",
          "What cytoplasmic factor is involved in the suppression of NFkappaB binding",
          "What is IL-2 mediated by anti-CD3-stimulated T cells?",
          "What suppressed IL-2 secretion?",
          "What cells were used in the study?",
          "What group of patients had a lower secretion of IL-2?"
        ]
      }
    }
  },
  "asked": {
    "What was secreted by anti-CD3-stimulated cord blood mononu": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.3892018795013428,
        "ground_truth": {
          "IL-2": {
            "bertscore": 0.6760646104812622,
            "f1": 0
          }
        }
      }
    },
    "What was IL-2 blunted by anti-CD3-stimulated cord blood": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.07657498121261597,
        "ground_truth": {
          "secretion": {
            "bertscore": 0.7148057818412781,
            "f1": 0
          }
        }
      }
    },
    "What was the only way to blunt IL-2 secretion?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.053160905838012695,
        "ground_truth": {
          "anti-CD3-stimulated cord blood mononuclear cells": {
            "bertscore": 0.5685397386550903,
            "f1": 0
          }
        }
      }
    },
    "What cells were used to stimulate IL-2 secretion?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "T cells",
        "answerability": 0.6627988815307617,
        "ground_truth": {
          "control cells": {
            "bertscore": 0.8762664794921875,
            "f1": 0.5
          }
        }
      }
    },
    "What group of cells were shown to have a higher secretion of IL-2 than": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.25465506315231323,
        "ground_truth": {
          "adults": {
            "bertscore": 0.7023347616195679,
            "f1": 0
          }
        }
      }
    }
  }
}